JEPQ vs. PBE
JEPQ (JPMorgan Nasdaq Equity Premium Income ETF) and PBE (Invesco Dynamic Biotechnology & Genome ETF) are both exchange-traded funds - JEPQ is a Nasdaq-100 fund tracking the Nasdaq-100 Index, while PBE is a Health & Biotech Equities fund tracking the Dynamic Biotech & Genome Intellidex Index (AMEX). Both are passively managed. Over the past 3 years, JEPQ returned 20.72%/yr vs 10.91%/yr for PBE. At a 0.49 correlation, their price movements are largely independent. JEPQ charges 0.35%/yr vs 0.59%/yr for PBE.
Performance
JEPQ vs. PBE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JEPQ achieves a 10.23% return, which is significantly higher than PBE's 3.32% return.
JEPQ
- 1D
- 2.21%
- 1M
- 3.31%
- YTD
- 10.23%
- 6M
- 11.56%
- 1Y
- 29.39%
- 3Y*
- 20.72%
- 5Y*
- —
- 10Y*
- —
PBE
- 1D
- 0.81%
- 1M
- 4.85%
- YTD
- 3.32%
- 6M
- 5.17%
- 1Y
- 34.13%
- 3Y*
- 10.91%
- 5Y*
- 2.31%
- 10Y*
- 8.90%
JEPQ vs. PBE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
JEPQ JPMorgan Nasdaq Equity Premium Income ETF | 10.23% | 15.18% | 24.85% | 36.28% | -11.16% |
PBE Invesco Dynamic Biotechnology & Genome ETF | 3.32% | 24.84% | 1.10% | 3.71% | 10.49% |
Correlation
The correlation between JEPQ and PBE is 0.36, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.36 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.42 |
Correlation (All Time) Calculated using the full available price history since May 4, 2022 | 0.49 |
The correlation between JEPQ and PBE shifts across timeframes, from 0.36 (1 year) to 0.49 (all time), reflecting how their relationship changes across market environments.
JEPQ vs. PBE - Sectors Allocation Comparison
Sectors
JEPQ
PBE
Technology
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Healthcare
Industrials
-
Utilities
-
Basic Materials
-
Financial Services
Energy
-
Real Estate
-
Technology
JEPQ
PBE
-
Communication Services
JEPQ
PBE
-
Consumer Cyclical
JEPQ
PBE
-
Consumer Defensive
JEPQ
PBE
-
Healthcare
JEPQ
PBE
Industrials
JEPQ
PBE
-
Utilities
JEPQ
PBE
-
Basic Materials
JEPQ
PBE
-
Financial Services
JEPQ
PBE
Energy
JEPQ
PBE
-
Real Estate
JEPQ
PBE
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JEPQ vs. PBE — Risk / Return Rank
JEPQ
PBE
JEPQ vs. PBE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) and Invesco Dynamic Biotechnology & Genome ETF (PBE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| JEPQ | PBE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.51 | ||
| Sortino ratioReturn per unit of downside risk | +0.37 | ||
| Omega ratioGain probability vs. loss probability | 1.46 | 1.31 | +0.15 |
| Calmar ratioReturn relative to maximum drawdown | 3.35 | 2.92 | +0.43 |
| Martin ratioReturn relative to average drawdown | 15.94 | 8.21 | +7.73 |
Loading charts...
Drawdowns
JEPQ vs. PBE - Drawdown Comparison
The maximum JEPQ drawdown since its inception was -20.07%, smaller than the maximum PBE drawdown of -45.69%. Use the drawdown chart below to compare losses from any high point for JEPQ and PBE.
Loading charts...
Drawdown Indicators
| JEPQ | PBE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -20.07% | -45.69% | +25.62% |
Max Drawdown (1Y)Largest decline over 1 year | -8.82% | -11.73% | +2.91% |
Max Drawdown (3Y)Largest decline over 3 years | -20.07% | -22.43% | +2.36% |
Max Drawdown (5Y)Largest decline over 5 years | — | -34.71% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -37.84% | — |
Current DrawdownCurrent decline from peak | 0.00% | -1.00% | +1.00% |
Average DrawdownAverage peak-to-trough decline | -3.41% | -16.21% | +12.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.85% | 4.17% | -2.32% |
Volatility
JEPQ vs. PBE - Volatility Comparison
The current volatility for JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) is 5.42%, while Invesco Dynamic Biotechnology & Genome ETF (PBE) has a volatility of 6.04%. This indicates that JEPQ experiences smaller price fluctuations and is considered to be less risky than PBE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JEPQ | PBE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.42% | 6.04% | -0.62% |
Volatility (6M)Calculated over the trailing 6-month period | 10.44% | 13.67% | -3.23% |
Volatility (1Y)Calculated over the trailing 1-year period | 12.78% | 19.01% | -6.23% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.76% | 22.48% | -5.72% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.76% | 24.91% | -8.15% |
JEPQ vs. PBE - Expense Ratio Comparison
JEPQ has a 0.35% expense ratio, which is lower than PBE's 0.59% expense ratio.
Dividends
JEPQ vs. PBE - Dividend Comparison
JEPQ's dividend yield for the trailing twelve months is around 10.00%, more than PBE's 1.02% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JEPQ JPMorgan Nasdaq Equity Premium Income ETF | 10.00% | 10.53% | 9.65% | 10.03% | 9.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PBE Invesco Dynamic Biotechnology & Genome ETF | 1.02% | 1.00% | 0.05% | 0.02% | 0.00% | 0.00% | 0.04% | 0.00% | 0.00% | 0.57% | 0.38% | 1.12% |
Frequently Asked Questions
JEPQ and PBE have a correlation of 0.36, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PBE has higher volatility (6.04%) compared to JEPQ (5.42%). In terms of maximum drawdown, JEPQ dropped -20.07% vs PBE's -45.69%.
On 3-year performance, JEPQ leads with 20.72% vs 10.91% for PBE. On fees, JEPQ is cheaper at 0.35% per year. On volatility, JEPQ has been the lower-risk option at 5.42%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, JEPQ has performed better with a 20.72% return vs 10.91%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
JEPQ is cheaper with a 0.35% expense ratio, compared with 0.59% for PBE.
JEPQ has the higher dividend yield at 10.00%, compared with 1.02% for PBE.
JEPQ is categorized as Nasdaq-100, while PBE is Health & Biotech Equities. JEPQ tracks Nasdaq-100 Index, while PBE tracks Dynamic Biotech & Genome Intellidex Index (AMEX). They also come from different issuers: JPMorgan and Invesco. Their fees differ too: 0.35% for JEPQ and 0.59% for PBE.
JEPQ currently has the higher Sharpe Ratio (2.31 vs 1.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JEPQ and PBE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer